根治性膀胱切除术中输尿管冰冻切片分析是否仍有价值?
该回顾性研究纳入1081例接受根治性膀胱切除术的膀胱癌患者,术中常规行双侧输尿管远端冰冻切片分析。结果显示冰冻切片诊断敏感度98.6%、特异度99.5%,切缘阳性与上尿路复发、总生存及癌症特异性生存恶化相关,水肿肾、T3-T4期、膀胱原位癌及三角区肿瘤为切缘阳性独立预测因素。
要点
- 术中输尿管远端冰冻切片诊断准确率高,敏感度98.6%、特异度99.5%。
- 切缘阳性者5年上尿路无复发生存58% vs 78%,总生存48% vs 67%。
- 膀胱原位癌、三角区肿瘤、水肿肾及T3-T4期者切缘阳性风险更高。
核心结论
- 根治性膀胱切除术中输尿管远端冰冻切片分析诊断性能优异,可实现无癌吻合。
- 研究支持对膀胱原位癌、三角区肿瘤或水肿肾患者行术中冰冻切片分析,以指导术中决策和术后监测。
研究设计与样本
- 回顾性研究,纳入2010-2024年间1081例接受根治性膀胱切除术的膀胱癌患者。
- 所有病例均行双侧输尿管远端术中冰冻切片分析,根据最终输尿管远端切缘状态(阳性 vs 阴性)分层。
主要发现
- 139例(12.9%)术中冰冻切片显示输尿管远端切缘阳性。
- 冰冻切片敏感度为98.6%,特异度为99.5%。
- 多因素logistic回归显示,水肿肾(OR 1.75,P=0.014)、T3-T4期(OR 2.48,P=0.003)、膀胱原位癌(OR 7.94,P<0.001)及三角区肿瘤(OR 4.85,P<0.001)与术中冰冻切片切缘阳性独立相关。
- 切缘阳性与上尿路复发风险增加相关(5年上尿路无复发生存率:58% vs 78%;P=0.038)。
- 切缘阳性与更差的总生存(5年OS:48% vs 67%;P=0.039)和癌症特异性生存(5年CSS:60% vs 75%;P=0.0018)相关。
临床怎么用
- 对于膀胱原位癌、三角区肿瘤或水肿肾患者,术中行输尿管远端冰冻切片分析有助于指导是否追加切除。
- 冰冻切片切缘阳性患者术后需加强上尿路监测。
局限性
- 回顾性单中心研究设计。
- 未报告术中冰冻切片分析对最终切缘状态及远期肿瘤学结局的干预效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the utility of routine intra-operative frozen section analysis (iFSA) of distal ureteric margins during radical cystectomy (RC) for bladder cancer (BCa), focusing on diagnostic accuracy and oncological outcomes in a high-volume tertiary centre. PATIENTS AND METHODS: We retrospectively identified 1081 patients with BCa treated with RC (2010-2024). Bilateral iFSA of the distal ureters was performed in all cases. Patients were stratified according to final distal ureteric margin status (positive vs negative); if positive, additional resections were attempted intra-operatively. Diagnostic concordance between iFSA and final pathology was calculated. Kaplan-Meier curves were used to assess 5-year upper urinary tract recurrence (UUTR) free-survival, overall survival (OS), and cancer-specific survival (CSS). Univariable logistic regression and multivariable logistic regression (MLR) models identified variables associated with positive margins. RESULTS: Overall, 139 patients (12.9%) had positive distal ureteric margins at iFSA. The sensitivity and specificity of FSA were 98.6% and 99.5%, respectively. In MLR models, hydronephrosis (odds ratio [OR] 1.75, P = 0.014), T3-T4 stage (OR 2.48, P = 0.003), bladder carcinoma in situ (CIS; OR 7.94, P < 0.001) and trigonal tumour location (OR 4.85, P < 0.001) were independently associated with positive distal ureteric margins at iFSA. Positive margins were associated with increased risk of UUTR (5-year UUTR-free survival: 58% vs 78%; P = 0.038), worse OS (5-year OS: 48% vs 67%; P = 0.039), and worse CSS (5-year CSS: 60% vs 75%; P = 0.0018). CONCLUSION: Our study showed that iFSA of distal ureteric margins during RC for BCa provided excellent diagnostic performance and enabled cancer-free anastomosis. Our findings support iFSA, especially in patients with bladder CIS, trigonal tumours, or hydronephrosis, to guide intra-operative decisions and tailor postoperative surveillance.
引用
- Barretta A, Piazza P, Catanzaro C, et al. Is there still a role for ureteric frozen section analysis during radical cystectomy? BJU Int. 2025. PMID: 41454422. doi:10.1111/bju.70125
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。